# IFNW1

## Overview
IFNW1 is a gene that encodes the protein interferon omega 1, a member of the type I interferon family, which is integral to the immune response against viral infections. The protein interferon omega 1 functions as a cytokine, primarily involved in the regulation of immune cell activity and the induction of antiviral states through the expression of interferon-stimulated genes (ISGs) (Wittling2021Shared). It is rapidly expressed in response to viral infections, such as those caused by the Sendai virus, and operates within the cytoplasm and nucleus to enhance immune signaling pathways (Freaney2014HighDensity). The protein signals through a heterodimeric receptor composed of IFNAR1 and IFNAR2, activating transcription factors that are crucial for antiviral defense (Thomas2011Structural). The gene's clinical significance is highlighted by its association with various conditions, including melanoma and susceptibility to mycobacterial infections, as well as its potential role in predicting treatment outcomes in immunotherapy (Varzari2022Candidate; Lenci2012Influence; Refae2019Germinal).

## Function
IFNW1, or interferon omega 1, is a member of the type I interferon family, which plays a significant role in the immune response against viral infections. In healthy human cells, IFNW1 is involved in the regulation of immune cell activity and promotes antiviral states by inducing the expression of interferon-stimulated genes (ISGs) (Wittling2021Shared). These genes are crucial for mounting an effective antiviral response and modulating immune functions. 

IFNW1 is expressed in response to viral infections, such as those caused by the Sendai virus, and is rapidly induced within hours of infection, indicating its role in the immediate antiviral response (Freaney2014HighDensity). The protein is primarily active in the cytoplasm and nucleus, where it influences signaling pathways that enhance the immune system's ability to detect and respond to pathogens. IFNW1 signals through a heterodimeric receptor composed of IFNAR1 and IFNAR2, triggering both canonical and non-canonical signaling pathways. This signaling leads to the activation of transcription factors and the subsequent expression of ISGs, which are essential for antiviral defense and immune regulation (Thomas2011Structural). 

The presence of neutralizing autoantibodies against IFNW1 in certain conditions, such as autoimmune polyendocrinopathy syndrome and severe COVID-19, suggests its significant yet underappreciated role in human health and disease (Wittling2021Shared).

## Clinical Significance
Mutations and genetic variations in the IFNW1 gene have been associated with several clinical conditions, particularly in relation to melanoma and immune response. Studies have shown that specific polymorphisms near the IFNW1 gene, such as rs10964859 and rs10964862, are linked to reduced disease-free survival in melanoma patients. These polymorphisms are associated with a higher risk of metastasis and death, especially in patients who did not receive treatment and were homozygous for the variant allele of rs10964862 (Lenci2012Influence). 

The IFNW1 gene has also been implicated in susceptibility to mycobacterial infections. A homozygous variant, c.58G>A/p.(Gly20Arg), was identified as a potential contributor to disease susceptibility, suggesting a role for IFNW1 in the IFN-γ signaling pathway, which is crucial for immune defense against such infections (Varzari2022Candidate).

In the context of immunotherapy, the SNP rs10964859 in the IFNW1 gene has been associated with increased toxicity risk in patients undergoing treatment with PD-1/PD-L1 checkpoint inhibitors, highlighting the gene's potential role in predicting treatment outcomes (Refae2019Germinal). These findings underscore the clinical significance of IFNW1 in various disease contexts.


## References


[1. (Refae2019Germinal) Sadal Refae, Jocelyn Gal, Nathalie Ebran, Josiane Otto, Delphine Borchiellini, Frederic Peyrade, Emmanuel Chamorey, Patrick Brest, Gérard Milano, and Esma Saada-Bouzid. Germinal immunogenetics predict treatment outcome for pd-1/pd-l1 checkpoint inhibitors. Investigational New Drugs, 38(1):160–171, August 2019. URL: http://dx.doi.org/10.1007/s10637-019-00845-w, doi:10.1007/s10637-019-00845-w. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10637-019-00845-w)

[2. (Wittling2021Shared) Megen C. Wittling, Shannon R. Cahalan, Eric A. Levenson, and Ronald L. Rabin. Shared and unique features of human interferon-beta and interferon-alpha subtypes. Frontiers in Immunology, January 2021. URL: http://dx.doi.org/10.3389/fimmu.2020.605673, doi:10.3389/fimmu.2020.605673. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2020.605673)

[3. (Thomas2011Structural) Christoph Thomas, Ignacio Moraga, Doron Levin, Peter O. Krutzik, Yulia Podoplelova, Angelica Trejo, Choongho Lee, Ganit Yarden, Susan E. Vleck, Jeffrey S. Glenn, Garry P. Nolan, Jacob Piehler, Gideon Schreiber, and K. Christopher Garcia. Structural linkage between ligand discrimination and receptor activation by type i interferons. Cell, 146(4):621–632, August 2011. URL: http://dx.doi.org/10.1016/j.cell.2011.06.048, doi:10.1016/j.cell.2011.06.048. This article has 300 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2011.06.048)

[4. (Freaney2014HighDensity) Jonathan E. Freaney, Quanwei Zhang, Erbay Yigit, Rebecca Kim, Jonathan Widom, Ji-Ping Wang, and Curt M. Horvath. High-density nucleosome occupancy map of human chromosome 9p21–22 reveals chromatin organization of the type i interferon gene cluster. Journal of Interferon &amp; Cytokine Research, 34(9):676–685, September 2014. URL: http://dx.doi.org/10.1089/jir.2013.0118, doi:10.1089/jir.2013.0118. This article has 16 citations.](https://doi.org/10.1089/jir.2013.0118)

[5. (Lenci2012Influence) Romina Elizabeth Lenci, Melanie Bevier, Andreas Brandt, Justo Lorenzo Bermejo, Antje Sucker, Iris Moll, Dolores Planelles, Celia Requena, Eduardo Nagore, Kari Hemminki, Dirk Schadendorf, and Rajiv Kumar. Influence of genetic variants in type i interferon genes on melanoma survival and therapy. PLoS ONE, 7(11):e50692, November 2012. URL: http://dx.doi.org/10.1371/journal.pone.0050692, doi:10.1371/journal.pone.0050692. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0050692)

[6. (Varzari2022Candidate) Alexander Varzari, Igor V. Deyneko, Gitte Hoffmann Bruun, Maja Dembic, Winfried Hofmann, Victor M. Cebotari, Sergei S. Ginda, Brage S. Andresen, and Thomas Illig. Candidate genes and sequence variants for susceptibility to mycobacterial infection identified by whole-exome sequencing. Frontiers in Genetics, October 2022. URL: http://dx.doi.org/10.3389/fgene.2022.969895, doi:10.3389/fgene.2022.969895. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.969895)